Michael Koby

Michael Koby co-founded 1315 Capital in 2014, after spending his entire career as a healthcare investor and operator, including experience with more than 25 growth equity investments. Prior to founding 1315 Capital, Michael was a Managing Director at Palm Ventures, a private-equity focused family office where he led all healthcare investing. He currently serves on the boards of CHC Solutions, Integration Health, JDS Therapeutics, Mosaic Diagnostics, Nu-Tek Biosciences, Nutrisense, and Triple Ring Technologies, and is a board observer for Biocoat. Michael also serves on the Executive Committee of the Cornell Dyson School Advisory Counsel and is a member of the Young President’s Organization.

Before Palm Ventures, Michael spent over a decade as an investor, including before and after business school, at Galen Partners, a healthcare growth equity investment firm. He also held business development roles at Novoste Corporation and Medtronic, Inc. Michael started his career as a healthcare investment banking analyst at Dillon, Read & Co.

Michael received a BSc from Cornell University and an MBA in Healthcare Management from The Wharton School.